Cargando…
High expression of TARS is associated with poor prognosis of endometrial cancer
Introduction: Endometrial cancer is the second largest and most common cancer in the world. It is urgent to explore novel biomarkers. Methods: Data were obtained from The Cancer Genome Atlas (TCGA) database. The receiver operating characteristic (ROC) curves, Kaplan-Meier curves and Cox analysis, no...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10042687/ https://www.ncbi.nlm.nih.gov/pubmed/36881401 http://dx.doi.org/10.18632/aging.204558 |
_version_ | 1784912984548573184 |
---|---|
author | Si, Lihui Liu, Lianchang Yang, Ruiqi Li, Wenxin Xu, Xiaohong |
author_facet | Si, Lihui Liu, Lianchang Yang, Ruiqi Li, Wenxin Xu, Xiaohong |
author_sort | Si, Lihui |
collection | PubMed |
description | Introduction: Endometrial cancer is the second largest and most common cancer in the world. It is urgent to explore novel biomarkers. Methods: Data were obtained from The Cancer Genome Atlas (TCGA) database. The receiver operating characteristic (ROC) curves, Kaplan-Meier curves and Cox analysis, nomograms, gene set enrichment analysis (GSEA) were conducted. Cell proliferation experiments were performed in Ishikawa cell. Results: TARS was significantly highly expressed in serous type, G3 grade, and deceased status. Significant association was between high TARS expression with poor overall survival (P = 0.0012) and poor disease specific survival (P = 0.0034). Significant differences were observed in advanced stage, G3 and G4, and old. The stage, diabetes, histologic grade, and TARS expression showed independent prognostic value for overall survival of endometrial cancer. The stage, histologic grade, and TARS expression showed independent prognostic value for disease specific survival of endometrial cancer. Activated CD4(+) T cell, effector memory CD4(+) T cell, memory B cell and type 2 T helper cell may participate in the high TARS expression related immune response in endometrial cancer. The CCK-8 results showed significantly inhibited cell proliferation in si-TARS (P < 0.05) and promoted cell proliferation in O-TARS (P < 0.05), confirmed by the colony formation and live/dead staining. Conclusion: High TARS expression was found in endometrial cancer with prognostic and predictive value. This study will provide new biomarker TARS for diagnosis and prognosis of endometrial cancer. |
format | Online Article Text |
id | pubmed-10042687 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Impact Journals |
record_format | MEDLINE/PubMed |
spelling | pubmed-100426872023-03-29 High expression of TARS is associated with poor prognosis of endometrial cancer Si, Lihui Liu, Lianchang Yang, Ruiqi Li, Wenxin Xu, Xiaohong Aging (Albany NY) Research Paper Introduction: Endometrial cancer is the second largest and most common cancer in the world. It is urgent to explore novel biomarkers. Methods: Data were obtained from The Cancer Genome Atlas (TCGA) database. The receiver operating characteristic (ROC) curves, Kaplan-Meier curves and Cox analysis, nomograms, gene set enrichment analysis (GSEA) were conducted. Cell proliferation experiments were performed in Ishikawa cell. Results: TARS was significantly highly expressed in serous type, G3 grade, and deceased status. Significant association was between high TARS expression with poor overall survival (P = 0.0012) and poor disease specific survival (P = 0.0034). Significant differences were observed in advanced stage, G3 and G4, and old. The stage, diabetes, histologic grade, and TARS expression showed independent prognostic value for overall survival of endometrial cancer. The stage, histologic grade, and TARS expression showed independent prognostic value for disease specific survival of endometrial cancer. Activated CD4(+) T cell, effector memory CD4(+) T cell, memory B cell and type 2 T helper cell may participate in the high TARS expression related immune response in endometrial cancer. The CCK-8 results showed significantly inhibited cell proliferation in si-TARS (P < 0.05) and promoted cell proliferation in O-TARS (P < 0.05), confirmed by the colony formation and live/dead staining. Conclusion: High TARS expression was found in endometrial cancer with prognostic and predictive value. This study will provide new biomarker TARS for diagnosis and prognosis of endometrial cancer. Impact Journals 2023-03-06 /pmc/articles/PMC10042687/ /pubmed/36881401 http://dx.doi.org/10.18632/aging.204558 Text en Copyright: © 2023 Si et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Si, Lihui Liu, Lianchang Yang, Ruiqi Li, Wenxin Xu, Xiaohong High expression of TARS is associated with poor prognosis of endometrial cancer |
title | High expression of TARS is associated with poor prognosis of endometrial cancer |
title_full | High expression of TARS is associated with poor prognosis of endometrial cancer |
title_fullStr | High expression of TARS is associated with poor prognosis of endometrial cancer |
title_full_unstemmed | High expression of TARS is associated with poor prognosis of endometrial cancer |
title_short | High expression of TARS is associated with poor prognosis of endometrial cancer |
title_sort | high expression of tars is associated with poor prognosis of endometrial cancer |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10042687/ https://www.ncbi.nlm.nih.gov/pubmed/36881401 http://dx.doi.org/10.18632/aging.204558 |
work_keys_str_mv | AT silihui highexpressionoftarsisassociatedwithpoorprognosisofendometrialcancer AT liulianchang highexpressionoftarsisassociatedwithpoorprognosisofendometrialcancer AT yangruiqi highexpressionoftarsisassociatedwithpoorprognosisofendometrialcancer AT liwenxin highexpressionoftarsisassociatedwithpoorprognosisofendometrialcancer AT xuxiaohong highexpressionoftarsisassociatedwithpoorprognosisofendometrialcancer |